Markets lower ahead of GDP data, Sun Pharma slips after reporting a loss for Q4
Advertisement

Markets lower ahead of GDP data, Sun Pharma slips after reporting a loss for Q4

By Reuters

  • 31 May 2022
Markets lower ahead of GDP data, Sun Pharma slips after reporting a loss for Q4
Credit: Reuters

Markets fell on Tuesday ahead of key economic growth data, while a rally in technology stocks lost steam and Sun Pharmaceutical Industries dropped after the company posted a loss for the March quarter.

The Nifty was down 0.58% at around 16,560 in early trade, while Sensex fell 0.73% to around 55,520.

Over the last three sessions, both indices rose helped by a rally in beaten down technology stocks. On Monday, the benchmark indices added nearly 2%, as auto stocks also joined a broader rally after upbeat March-quarter results from Mahindra and Mahindra.

Advertisement

On Tuesday, Asian stocks also lost ground after hot inflation reading in Germany renewed fears about the pace and scale of looming interest rate hikes.

A rise in Brent crude futures after the European Union agreed to slash oil imports from Russia by the end of 2022 also weighed on sentiment.

In domestic trading, Nifty IT snapped a three-day rally and dropped 1.5%.

Advertisement

Shares of Sun Pharma tumbled 4.2% and were the top losers on the Nifty, after the drugmaker reported a consolidated net loss after tax of Rs 2,277 crore ($293.3 million) for the March quarter.

Life Insurance Corporation of India, the country's biggest insurer and largest domestic financial investor, dropped 2.9% after reporting lower March quarter profit in its first results since a lacklustre market debut earlier this month.

However, auto stocks extended Monday's gains, rising 1.2% to a three-month high. Shares of Mahindra and Mahindra rose 3.1% to a record peak for a second straight session and was the top percentage gainer on the Nifty 50 index.

Advertisement

Focus was on GDP data expected later in the day. India's economic recovery from the COVID-19 pandemic likely stumbled again in the first quarter of this year, a Reuters poll last week showed.

Share article on

Advertisement
Advertisement